John P. Butler
CEO, President & DirectorMr. John P. Butler, MBA, serves as Non-Executive Director at Wren Therapeutics Limited since 2023. He has been the Chief Executive Officer and President of Akebia Therapeutics, Inc. since September 2013 and served as its Interim Principal Financial Officer since March 22, 2024 until June 2024 and served as its Interim Chief Financial Officer and Principal Accounting Officer since June 23, 2023 until July 17, 2023. Mr. Butler served as Chief Executive Officer of Inspiration Biopharmaceuticals, Inc. from October 11, 2011 to April 2013. He served as the President of Personalized Genetic Health at Genzyme Corporation since May 2010. He served as Senior Vice President and President of Cardiometabolic & Renal at Genzyme Corporation. He served as President of Renal business of Genzyme Corporation. He served as Senior Vice President and General Manager of the Renal business of Genzyme Corporation since July 16, 2003. Mr. Butler has experience commercializing innovative therapies, leading businesses that served rare disease patient populations. He joined Genzyme in 1997 as Product Manager for Renagel and served as its Vice President of strategic planning and Vice President of Renagel Europe. He served as President of the Rare Genetic Diseases Business at Genzyme Corporation. From 2002 to 2010, Mr. Butler led Genzyme's renal division. Prior to his work at Genzyme from 1997 to 2011, he worked in sales and marketing at Amgen Inc. and Hoffmann-La Roche. He served as a Director of Relypsa, Inc. from September 26, 2013 to September 2016. Mr. Butler began serving on the Health Section Governing Board of Biotechnology Innovation Organization. He has been a Director of Akebia Therapeutics, Inc. since July 2013. He has been a Chairperson of the Board of Keryx Biopharmaceuticals, Inc. since December 12, 2018. He has been Independent Director of Zynerba Pharmaceuticals, Inc. since April 2018. He was Chairman of Keryx Biopharmaceuticals from December 2015 to September 2017. He served as an Independent Director of Keryx Biopharmaceuticals Inc. from December 10, 2015 to September 13, 2017. He served as a Director of Inspiration Biopharmaceuticals, Inc. He served as Chairman of the Board of Trustees for the American Kidney Fund from 2013 to 2015. Mr. Butler has an M. B.A. from Baruch College, City University of New York and a B. A. in Chemistry from Manhattan College.
Positions
- Company NameAkebia Therapeutics, Inc.Stock CodeAKBAPositionCEO, President & DirectorColleagues
- AAAdrian AdamsIndependent Chairperson
- EJErik John OstrowskiChief Business Officer, Senior VP, CFO & Treasurer
- SKSteven Keith BurkeSenior VP and Chief Research & Development Officer
- RCRichard C. MalabreSenior VP & Chief Accounting Officer
- JMJustin McCueSenior VP & Chief Technology Officer
- CSCynthia SmithIndependent Director
- MWMichael W. RogersIndependent Director
- RERonald E. FriesonIndependent Director
